Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor palbociclib

Int J Dermatol. 2023 Feb;62(2):e98-e100. doi: 10.1111/ijd.16356. Epub 2022 Jul 3.

Authors

Maurizio Romagnuolo^{1

2}, Silvia Alberti Violetti^{1

2}, Davide Riva^{1

2}, Francesco Barberi^{1

2}, Chiara Moltrasio^{2

3}

Affiliations

¹ Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
² Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
³ Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.

PMID: 35781265
DOI: 10.1111/ijd.16356

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms*
Cyclin-Dependent Kinase 4
Female
Humans
Piperazines / adverse effects
Protein Kinase Inhibitors / adverse effects
Pyridines / adverse effects
Vitiligo* / chemically induced

Substances

palbociclib
Cyclin-Dependent Kinase 4
Pyridines
Piperazines
Protein Kinase Inhibitors